Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University Hospitals of Cleveland Plans New Research Building
University Hospitals of Cleveland is planning a new $110 million, 320,000-gsf Research Institute Building for advanced biomedical research programs, scheduled to open in 2003. Research functions are distributed over eight floors, including two floors below grade dedicated to lab and building support. The ground floor level includes a conferences center; administrative offices are on the second floor. Five floors of generic research labs, lab support, and offices will accommodate 120 researchers on each floor.
DFI Group Plans Ethanol R&D Center
DFI Group Inc., a commercial and industrial developer, is considering a site in the Charlotte, N.C., area to build an ethanol R&D center. An existing building in Monroe is under consideration. A section of the multimillion-dollar facility would be designed to produce 3 million gallons of ethanol annually. DFI Construction Inc., formed this year, supports the company’s industrial project construction needs in the Southeast.
Maryland Science/Tech Center Nears Phase I Completion
Maryland Science and Technology Center, a $60 million, 14-building complex, expects to complete Phase I of construction—a total of 120,000 sf of space in one office building and two flex and R&D buildings—by February 2002. The buildings were designed by Robert T. Hoffman. Phase II construction will create four flex and R&D facilities. MEI Properties is the developer of the project at the 466-acre office park.
Dow Chemical Plans Biotech Contract Manufacturing Plant
Dow Chemical Co., based in Midland, Mich., is planning to transform a 55,000-sf facility previously occupied by Collaborative Group Ltd.’s Biotechnology Services Division into a large-molecule drugs contract manufacturing plant to serve the biotech industry. The facility will have a 50,000-liter capacity. World-wide, the capacity to produce large-molecule drugs stands at about 380,000 liters, with a critical shortage of capacity anticipated by 2005.
Charles River Labs Builds Transgenic Facility
Charles River Laboratories International, a provider of contract services and research animals to the biotech and pharmaceutical industries, has a 68,000-sf transgenic facility under construction at their Wilmington headquarters. Completion of the building is anticipated in spring 2002. Demand for the company’s products increased significantly as the mapping of the human genome revealed genetic similarities between mice and humans.